US Bancorp’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,352
| Closed | -$1K | – | 3943 |
|
|
2019
Q4 | $1K | Sell |
1,352
-160
| -11% | -$123 | ﹤0.01% | 3637 |
|
|
2019
Q3 | $1K | Buy |
1,512
+160
| +12% | +$86 | ﹤0.01% | 3564 |
|
|
2019
Q2 | $1K | Hold |
1,352
| – | – | ﹤0.01% | 3604 |
|
|
2019
Q1 | $1K | Sell |
1,352
-10,000
| -88% | -$4.67K | ﹤0.01% | 3568 |
|
|
2018
Q4 | $5K | Sell |
11,352
-318
| -3% | -$158 | ﹤0.01% | 3248 |
|
|
2018
Q3 | $6K | Buy |
11,670
+10,000
| +599% | +$5.36K | ﹤0.01% | 3299 |
|
|
2018
Q2 | $1K | Buy |
1,670
+373
| +29% | +$174 | ﹤0.01% | 3598 |
|
|
2018
Q1 | $1K | Hold |
1,297
| – | – | ﹤0.01% | 3591 |
|
|
2017
Q4 | $0 | Sell |
1,297
-46
| -3% | -$17 | ﹤0.01% | 3797 |
|
|
2017
Q3 | $0 | Hold |
1,343
| – | – | ﹤0.01% | 3784 |
|
|
2017
Q2 | $0 | Buy |
1,343
+14
| +1% | +$6 | ﹤0.01% | 3749 |
|
|
2017
Q1 | $1K | Sell |
1,329
-463
| -26% | -$203 | ﹤0.01% | 3535 |
|
|
2016
Q4 | $1K | Sell |
1,792
-370
| -17% | -$125 | ﹤0.01% | 3524 |
|
|
2016
Q3 | $0 | Sell |
2,162
-376
| -15% | -$95 | ﹤0.01% | 3788 |
|
|
2016
Q2 | $0 | Sell |
2,538
-200
| -7% | -$34 | ﹤0.01% | 3816 |
|
|
2016
Q1 | $0 | Sell |
2,738
-21
| -0.8% | -$2 | ﹤0.01% | 3842 |
|
|
2015
Q4 | $0 | Sell |
2,759
-1,028
| -27% | -$145 | ﹤0.01% | 3876 |
|
|
2015
Q3 | $0 | Hold |
3,787
| – | – | ﹤0.01% | 3856 |
|
|
2015
Q2 | $3K | Buy |
3,787
+7
| +0.2% | +$5 | ﹤0.01% | 3415 |
|
|
2015
Q1 | $3K | Hold |
3,780
| – | – | ﹤0.01% | 3426 |
|
|
2014
Q4 | $3K | Hold |
3,780
| – | – | ﹤0.01% | 3406 |
|
|
2014
Q3 | $1K | Sell |
3,780
-100
| -3% | -$49 | ﹤0.01% | 3489 |
|
|
2014
Q2 | $1K | Sell |
3,880
-2,230
| -36% | -$1.08K | ﹤0.01% | 3477 |
|
|
2014
Q1 | $3K | Sell |
6,110
-970
| -14% | -$361 | ﹤0.01% | 3338 |
|
|
2013
Q4 | $2K | Sell |
7,080
-32
| -0.4% | -$39 | ﹤0.01% | 3338 |
|
|
2013
Q3 | $15K | Buy |
7,112
+1,000
| +16% | +$1.91K | ﹤0.01% | 2788 |
|
|
2013
Q2 | $12K | Buy |
+6,112
| New | +$10.7K | ﹤0.01% | 2830 |
|
US Bancorp's GCVRZ Position: Q1 2020 in Review
US Bancorp sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 1,352 shares — an estimated $1K sold.
US Bancorp first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $15K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- US Bancorp reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- US Bancorp sold 1,352 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $1K.
- US Bancorp first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- US Bancorp's Sanofi Contingent Value Rights position peaked at $15K in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on US Bancorp's 13F filing for Q1 2020, filed 13 May 2020.